Article
Inadvertent presence of pluripotent cells in monolayers derived from differentiated embryoid bodies.
The International journal of developmental biology - 1 Jan 2007
Ramírez Miguel A, Pericuesta Eva, Fernández-González Raúl, Pintado Belén, Gutiérrez-Adán Alfonso
Abstract excerpt
The therapeutic use of embryonic stem (ES)-derived cells is restricted by a risk of teratoma formation. To test the hypothesis that some cells with pluripotency characteristics remain following the differentiation of embryoid bodies (EB) into monolayer cells, we transformed mouse ES cells using constructs comprised of the mTert promoter coupled to green fluorescent protein. In this manner, EBs could be identified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
